False Larch
Pseudolarix
Pseudolarix is a coniferous tree native to East Asia. While traditional uses of Pseudolarix are not well-documented, scientific research has shown promising results. Studies indicate that pseudolarolide B from this plant enhances PP2A holoenzyme assembly and anti-inflammatory activity, suggesting potential benefits in inflammation-related conditions. Additionally, pseudolaric acid B induces ferroptosis in lung cancer cells and causes G2/M phase arrest in canine mammary tumor cells, hinting at possible anticancer properties. Notably, Pseudolarix kaempferi extract improved symptoms of non-alcoholic fatty liver disease by modulating gut microbiota and increasing tryptophan metabolites that activate AhR to reduce hepatic lipogenesis. Safety profiles for this plant are currently favorable with no major issues recorded; however, further research is needed to confirm these findings. There are no known drug interactions reported at present.
- Best evidence
- D
- Cautions
- —
Informational only. Traditional use does not mean proven effectiveness. Evidence and safety vary — check the cited sources.
What the science says
- Pseudolaric acid B induced G2/M phase arrest in canine mammary tumor cells by targeting CDK1.
- Pseudolaric acid B induces ferroptosis in lung cancer cells via JNK/ERK-mediated upregulation of survivin.
- Pseudolarolide B covalently binds to PPP2R1A, enhancing PP2A holoenzyme assembly and anti-inflammatory activity.
- Pseudolaric acid B (PAB) from Pseudolarix kaempferi improved symptoms of high-fat diet-induced MAFLD by modulating gut microbiota and increasing tryptophan metabolite cinnabarinic acid, which activated AhR to reduce hepatic lipogenesis.
Frequently asked questions
What is False Larch?
False Larch (Pseudolarix) is a plant documented in FolkKB's traditional-medicine reference, drawn from sourced literature and cross-checked against the evidence.
What does the scientific evidence say about False Larch?
4 sourced findings are recorded for False Larch; the strongest carries evidence grade D. For example: Pseudolaric acid B induced G2/M phase arrest in canine mammary tumor cells by targeting CDK1.
How strong is the evidence for False Larch?
The strongest finding for False Larch carries evidence grade D — preliminary or traditional. Grades run A (strongest) to D (preliminary or traditional).
Is False Larch safe? What are the side effects?
No major safety issues are recorded for False Larch in our sources, but the data may be incomplete. Consult a qualified professional before use.
Does False Larch interact with medications?
No drug interactions are recorded for False Larch in our sources. This does not rule them out — check with a pharmacist.
What are the common names of False Larch?
False Larch is also known as: Лжелиственница, Mélèze doré de Chine.
Is False Larch a proven treatment?
No. FolkKB is informational only. Traditional use and early findings are not proof of efficacy or safety — consult a qualified professional and never self-treat.
Sources
- T2 Gut microbiota-based metabolism contributes to the protection of pseudolaric acid B against MAFLD. literature abstract metadata
- T2 Pseudolaric acid B induces G2/M phase arrest in canine mammary tumor cells by targeting CDK1. literature abstract metadata
- T2 Pseudolaric acid B promotes lung cancer cells ferroptosis depending on JNK/ERK-mediated upregulation of survivin. literature abstract metadata
- T2 Covalent targeting of PP2A scaffold subunit PPP2R1A by Pseudolarolide B enhances holoenzyme assembly to exert anti-inflammatory activity. literature abstract metadata